Mary Washington Healthcare performs the Transcatheter-Edge-to-Edge Repair (TEER) of the mitral valve using the Abbott MitraClip™. TEER is a minimally invasive treatment option for select patients with mitral valve regurgitation, often called a “leaky” heart valve—without open-heart surgery. This advanced procedure is now available at Mary Washington Hospital, delivered by an experienced structural heart team close to home.
Patients who once had limited options may now find relief from symptoms such as shortness of breath and fatigue and return to doing more of what they enjoy.
TEER is a catheter-based heart valve repair procedure designed to reduce mitral valve leakage.
During the procedure:
Because the procedure does not require opening the chest or stopping the heart, it offers a less invasive alternative for appropriate patients.
TEER may be an option for patients who:
Eligibility is determined by a multidisciplinary structural heart team, using advanced cardiac imaging and individualized clinical evaluation.
For eligible patients, TEER can offer:
Many patients experience meaningful relief while avoiding the physical stress of major surgery.
Patients receiving TEER at Mary Washington Healthcare benefit from:
Your care team works closely with your referring cardiologist to ensure continuity and coordination at every step.